Is EVAR the treatment of choice for aortoenteric fistula?
Lonn, L ; Dias, Nuno LU
; Veith Schroeder, T
and Resch, Tim
LU
(2010)
In Journal of Cardiovascular Surgery
51(3).
p.319-327
- Abstract
- Aortoenteric fistula formation is a devastating condition regardless of whether it is primary or secondary (i.e. after previous aneurysm repair) in nature. Patients present with signs and symptoms of gastrointestinal bleeding with or without signs of systemic infection and are often in a very poor clinical condition. Conventional treatment consists of extensive open surgery (extra-anatomical bypass or aortic ligation), closure of fistula tract and complete removal of any prosthetic material. This treatment is associated with high morbidity and mortality and therefore more minimally invasive options with endovascular repair have been attempted. Endovascular repair is often successful in the short-term achieving favorable immediate outcome.... (More)
- Aortoenteric fistula formation is a devastating condition regardless of whether it is primary or secondary (i.e. after previous aneurysm repair) in nature. Patients present with signs and symptoms of gastrointestinal bleeding with or without signs of systemic infection and are often in a very poor clinical condition. Conventional treatment consists of extensive open surgery (extra-anatomical bypass or aortic ligation), closure of fistula tract and complete removal of any prosthetic material. This treatment is associated with high morbidity and mortality and therefore more minimally invasive options with endovascular repair have been attempted. Endovascular repair is often successful in the short-term achieving favorable immediate outcome. In the presence of systemic infection, however, EVAR alone as an ultimate solution is often followed by repeat infection and bleeding. A staged combination of EVAR treatment for acute bleeding and aggressive infection treatment with systemic and local antibiotics, surgical abscess revision and fistula tract closure might be an option in fragile patients. For patients fit for open repair, EVAR can be used as a bridging procedure to definitive repair particularly in the setting of systemic infection. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1626363
- author
- Lonn, L
; Dias, Nuno
LU
; Veith Schroeder, T
and Resch, Tim
LU
- organization
- publishing date
- 2010
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Cardiovascular Surgery
- volume
- 51
- issue
- 3
- pages
- 319 - 327
- publisher
- Edizioni Minerva Medica
- external identifiers
-
- wos:000280895300005
- pmid:20523281
- scopus:77955372142
- ISSN
- 0021-9509
- language
- English
- LU publication?
- yes
- id
- 49653a2f-2a36-4e85-bd55-bdf931259d53 (old id 1626363)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/20523281?dopt=Abstract
- date added to LUP
- 2016-04-04 09:35:34
- date last changed
- 2022-03-23 06:19:43
@article{49653a2f-2a36-4e85-bd55-bdf931259d53,
abstract = {{Aortoenteric fistula formation is a devastating condition regardless of whether it is primary or secondary (i.e. after previous aneurysm repair) in nature. Patients present with signs and symptoms of gastrointestinal bleeding with or without signs of systemic infection and are often in a very poor clinical condition. Conventional treatment consists of extensive open surgery (extra-anatomical bypass or aortic ligation), closure of fistula tract and complete removal of any prosthetic material. This treatment is associated with high morbidity and mortality and therefore more minimally invasive options with endovascular repair have been attempted. Endovascular repair is often successful in the short-term achieving favorable immediate outcome. In the presence of systemic infection, however, EVAR alone as an ultimate solution is often followed by repeat infection and bleeding. A staged combination of EVAR treatment for acute bleeding and aggressive infection treatment with systemic and local antibiotics, surgical abscess revision and fistula tract closure might be an option in fragile patients. For patients fit for open repair, EVAR can be used as a bridging procedure to definitive repair particularly in the setting of systemic infection.}},
author = {{Lonn, L and Dias, Nuno and Veith Schroeder, T and Resch, Tim}},
issn = {{0021-9509}},
language = {{eng}},
number = {{3}},
pages = {{319--327}},
publisher = {{Edizioni Minerva Medica}},
series = {{Journal of Cardiovascular Surgery}},
title = {{Is EVAR the treatment of choice for aortoenteric fistula?}},
url = {{http://www.ncbi.nlm.nih.gov/pubmed/20523281?dopt=Abstract}},
volume = {{51}},
year = {{2010}},
}